Correlation Between VSee Health, and Eupraxia Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VSee Health, and Eupraxia Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VSee Health, and Eupraxia Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VSee Health, and Eupraxia Pharmaceuticals Common, you can compare the effects of market volatilities on VSee Health, and Eupraxia Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VSee Health, with a short position of Eupraxia Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of VSee Health, and Eupraxia Pharmaceuticals.

Diversification Opportunities for VSee Health, and Eupraxia Pharmaceuticals

0.05
  Correlation Coefficient

Significant diversification

The 3 months correlation between VSee and Eupraxia is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding VSee Health, and Eupraxia Pharmaceuticals Commo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eupraxia Pharmaceuticals and VSee Health, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VSee Health, are associated (or correlated) with Eupraxia Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eupraxia Pharmaceuticals has no effect on the direction of VSee Health, i.e., VSee Health, and Eupraxia Pharmaceuticals go up and down completely randomly.

Pair Corralation between VSee Health, and Eupraxia Pharmaceuticals

Given the investment horizon of 90 days VSee Health, is expected to under-perform the Eupraxia Pharmaceuticals. In addition to that, VSee Health, is 1.02 times more volatile than Eupraxia Pharmaceuticals Common. It trades about -0.06 of its total potential returns per unit of risk. Eupraxia Pharmaceuticals Common is currently generating about 0.1 per unit of volatility. If you would invest  255.00  in Eupraxia Pharmaceuticals Common on September 26, 2024 and sell it today you would earn a total of  51.00  from holding Eupraxia Pharmaceuticals Common or generate 20.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

VSee Health,  vs.  Eupraxia Pharmaceuticals Commo

 Performance 
       Timeline  
VSee Health, 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in VSee Health, are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical and fundamental indicators, VSee Health, may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Eupraxia Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Eupraxia Pharmaceuticals Common are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Eupraxia Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

VSee Health, and Eupraxia Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VSee Health, and Eupraxia Pharmaceuticals

The main advantage of trading using opposite VSee Health, and Eupraxia Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VSee Health, position performs unexpectedly, Eupraxia Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eupraxia Pharmaceuticals will offset losses from the drop in Eupraxia Pharmaceuticals' long position.
The idea behind VSee Health, and Eupraxia Pharmaceuticals Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing